Latest Insider Transactions at Arvinas, Inc. (ARVN)
This section provides a real-time view of insider transactions for Arvinas, Inc. (ARVN). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of ARVINAS, INC. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of ARVINAS, INC.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Nov 09
2021
|
Liam Ratcliffe Director |
SELL
Open market or private sale
|
Indirect |
33,008
-1.56%
|
$3,003,728
$91.97 P/Share
|
|
Nov 08
2021
|
Liam Ratcliffe Director |
SELL
Open market or private sale
|
Indirect |
81,054
-2.64%
|
$7,538,022
$93.66 P/Share
|
|
Nov 05
2021
|
Liam Ratcliffe Director |
SELL
Open market or private sale
|
Indirect |
33,094
-0.82%
|
$3,011,554
$91.97 P/Share
|
|
Nov 05
2021
|
Liam Ratcliffe Director |
SELL
Open market or private sale
|
Direct |
24,923
-58.27%
|
$2,243,070
$90.88 P/Share
|
|
Nov 05
2021
|
Liam Ratcliffe Director |
BUY
Exercise of conversion of derivative security
|
Direct |
18,423
+32.85%
|
$497,421
$27.82 P/Share
|
|
Nov 01
2021
|
John G Houston President and CEO |
SELL
Open market or private sale
|
Direct |
40,000
-1.55%
|
$3,480,000
$87.99 P/Share
|
|
Nov 01
2021
|
John G Houston President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
40,000
+4.38%
|
$640,000
$16.0 P/Share
|
|
Sep 07
2021
|
Timothy M Shannon Director |
SELL
Open market or private sale
|
Indirect |
36,411
-0.54%
|
$3,240,579
$89.43 P/Share
|
|
Sep 03
2021
|
Timothy M Shannon Director |
SELL
Open market or private sale
|
Indirect |
32,387
-0.94%
|
$2,752,895
$85.93 P/Share
|
|
Sep 02
2021
|
Timothy M Shannon Director |
SELL
Open market or private sale
|
Indirect |
51,765
-1.47%
|
$4,400,025
$85.88 P/Share
|
|
Sep 02
2021
|
John G Houston President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
4,690
+0.28%
|
$75,040
$16.0 P/Share
|
|
Sep 01
2021
|
Timothy M Shannon Director |
SELL
Open market or private sale
|
Indirect |
79,437
-1.09%
|
$6,911,019
$87.23 P/Share
|
|
Aug 31
2021
|
Timothy M Shannon Director |
SELL
Open market or private sale
|
Indirect |
59,355
-1.56%
|
$5,045,175
$85.8 P/Share
|
|
Aug 30
2021
|
Timothy M Shannon Director |
SELL
Open market or private sale
|
Indirect |
58,838
-0.75%
|
$5,060,068
$86.83 P/Share
|
|
Aug 27
2021
|
Timothy M Shannon Director |
SELL
Open market or private sale
|
Indirect |
45,026
-1.12%
|
$3,827,210
$85.72 P/Share
|
|
Aug 26
2021
|
Timothy M Shannon Director |
SELL
Open market or private sale
|
Indirect |
11,712
-0.58%
|
$995,520
$85.12 P/Share
|
|
Aug 26
2021
|
Bradley Albert Margus Director |
SELL
Open market or private sale
|
Indirect |
9,940
-83.25%
|
$844,900
$85.03 P/Share
|
|
Aug 25
2021
|
Timothy M Shannon Director |
SELL
Open market or private sale
|
Indirect |
14,267
-0.7%
|
$1,212,695
$85.03 P/Share
|
|
Aug 25
2021
|
Bradley Albert Margus Director |
SELL
Open market or private sale
|
Indirect |
20,000
-62.62%
|
$1,700,000
$85.0 P/Share
|
|
Aug 24
2021
|
Timothy M Shannon Director |
SELL
Open market or private sale
|
Indirect |
9,203
-0.22%
|
$800,661
$87.01 P/Share
|
|
Aug 23
2021
|
Timothy M Shannon Director |
SELL
Open market or private sale
|
Indirect |
1,599
-0.08%
|
$140,712
$88.01 P/Share
|
|
Aug 16
2021
|
Ian Taylor President, R&D |
SELL
Open market or private sale
|
Direct |
20,000
-7.15%
|
$1,740,000
$87.6 P/Share
|
|
Aug 16
2021
|
Ian Taylor President, R&D |
BUY
Exercise of conversion of derivative security
|
Direct |
20,000
+16.86%
|
$320,000
$16.0 P/Share
|
|
Aug 13
2021
|
Bradley Albert Margus Director |
SELL
Open market or private sale
|
Indirect |
5,828
-15.43%
|
$524,520
$90.03 P/Share
|
|
Aug 12
2021
|
Ronald Peck Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
1,363
-20.15%
|
$122,670
$90.54 P/Share
|
|
Aug 12
2021
|
Ronald Peck Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
4,011
+37.22%
|
-
|
|
Aug 11
2021
|
Bradley Albert Margus Director |
SELL
Open market or private sale
|
Indirect |
5,000
-11.69%
|
$450,000
$90.03 P/Share
|
|
Aug 02
2021
|
John G Houston President and CEO |
SELL
Open market or private sale
|
Direct |
45,922
-1.07%
|
$4,500,356
$98.82 P/Share
|
|
Aug 02
2021
|
John G Houston President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
45,922
+4.99%
|
$734,752
$16.0 P/Share
|
|
Jul 28
2021
|
Sean A Cassidy Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
17,242
-9.83%
|
$1,724,200
$100.0 P/Share
|
|
Jul 28
2021
|
Sean A Cassidy Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
17,242
+8.95%
|
$275,872
$16.0 P/Share
|
|
Jun 30
2021
|
Ronald Peck Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
20,000
-87.9%
|
$1,520,000
$76.69 P/Share
|
|
Jun 30
2021
|
Ronald Peck Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
20,000
+46.78%
|
$940,000
$47.38 P/Share
|
|
Jun 10
2021
|
John G Houston President and CEO |
SELL
Open market or private sale
|
Direct |
43,886
-1.71%
|
$3,554,766
$81.58 P/Share
|
|
Jun 10
2021
|
John G Houston President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
43,886
+4.79%
|
$702,176
$16.0 P/Share
|
|
Jun 09
2021
|
John G Houston President and CEO |
SELL
Open market or private sale
|
Direct |
700
-0.08%
|
$56,000
$80.15 P/Share
|
|
Jun 09
2021
|
John G Houston President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
700
+0.08%
|
$11,200
$16.0 P/Share
|
|
Apr 05
2021
|
Ian Taylor President, R&D |
SELL
Open market or private sale
|
Direct |
25,000
-8.61%
|
$1,650,000
$66.79 P/Share
|
|
Apr 05
2021
|
Ian Taylor President, R&D |
BUY
Exercise of conversion of derivative security
|
Direct |
25,000
+19.43%
|
$400,000
$16.0 P/Share
|
|
Mar 02
2021
|
John G Houston President and CEO |
SELL
Open market or private sale
|
Direct |
8,115
-0.97%
|
$624,855
$77.45 P/Share
|
|
Mar 02
2021
|
John G Houston President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
17,510
+2.05%
|
-
|
|
Mar 02
2021
|
Sean A Cassidy Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
2,221
-1.38%
|
$171,017
$77.45 P/Share
|
|
Mar 02
2021
|
Sean A Cassidy Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
4,792
+2.9%
|
-
|
|
Mar 02
2021
|
Ian Taylor President, R&D |
SELL
Open market or private sale
|
Direct |
894
-1.12%
|
$68,838
$77.45 P/Share
|
|
Mar 02
2021
|
Ian Taylor President, R&D |
BUY
Exercise of conversion of derivative security
|
Direct |
2,685
+3.27%
|
-
|
|
Feb 19
2021
|
Ian Taylor President, R&D |
BUY
Exercise of conversion of derivative security
|
Direct |
6,456
+7.75%
|
$103,296
$16.0 P/Share
|
|
Feb 17
2021
|
Sean A Cassidy Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
894
+0.29%
|
$14,304
$16.0 P/Share
|
|
Feb 16
2021
|
Ronald Peck Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
20,000
-87.9%
|
$1,540,000
$77.35 P/Share
|
|
Feb 16
2021
|
Ronald Peck Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
20,000
+46.78%
|
$520,000
$26.58 P/Share
|
|
Feb 16
2021
|
Sean A Cassidy Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
41,959
-2.9%
|
$3,272,802
$78.99 P/Share
|